Literature DB >> 25209481

Is tiered pricing the way for vaccines?

Manica Balasegaram1.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25209481     DOI: 10.1016/S0140-6736(14)61483-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).

Authors:  Gian Gandhi
Journal:  BMC Public Health       Date:  2015-11-30       Impact factor: 3.295

2.  The importance of vaccine stockpiling to respond to epidemics and remediate global supply shortages affecting immunization: strategic challenges and risks identified by manufacturers.

Authors:  Stephen Jarrett; Sonia Pagliusi; Rachel Park; Taufik Wilmansyah; Suresh Jadhav; Patricia Correa Santana; K R Krishnamurthy; Lingjiang Yang
Journal:  Vaccine X       Date:  2021-10-20

3.  Public support in the United States for global equity in vaccine pricing.

Authors:  Yee Chan; Gaurav Datt; Asadul Islam; Birendra Rai; Liang C Wang
Journal:  Sci Rep       Date:  2022-05-27       Impact factor: 4.996

Review 4.  Are good intentions putting the vaccination ecosystem at risk?

Authors:  Michael Watson; Eliot Faron de Goër
Journal:  Hum Vaccin Immunother       Date:  2016-06-06       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.